Antimalarials
Showing 51 - 75 of 203
Plasmodium Falciparum Malaria Trial in Huong Hoa (Imatinib combination therapy, Dihydroartemisinin-piperaquine)
Completed
- Plasmodium Falciparum Malaria
- Imatinib combination therapy
- Dihydroartemisinin-piperaquine
-
Huong Hoa, Quang Tri, VietnamA Tuc
Feb 8, 2021
Malaria,Falciparum, Children, Only Trial in Ouagadougou, Bamako (RABIPUR®, RTS,S/AS01, SMC with SP+AQ)
Completed
- Malaria,Falciparum
- Children, Only
- RABIPUR®
- +3 more
-
Ouagadougou, Burkina Faso
- +1 more
Mar 14, 2022
COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)
Evaluation of a Digital Microscope for Malaria
Completed
- Malaria
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Sep 1, 2020
Malaria Trial in Kampala (IPT with Dihydroartemisinin Piperaquine)
Recruiting
- Malaria
- IPT with Dihydroartemisinin Piperaquine
-
Kampala, UgandaMakerere College of Health Sciences
Feb 22, 2021
Child Health Trial in Rwanda (ePOCT+)
Recruiting
- Child Health
- ePOCT+
-
Bushekeri, Nyamasheke, Rwanda
- +31 more
Nov 21, 2022
Systemic Lupus Erythematosus Trial in Beijing (Placebo plus standard therapy, RC18 80 mg plus standard therapy, RC18 160 mg plus
Completed
- Systemic Lupus Erythematosus
- Placebo plus standard therapy
- +3 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 2, 2020
Malaria, Pregnancy Malaria, Cardiotoxicity Trial in Handeni (sulfadoxine-pyrimethamine (SP), dihydroartemisinin-piperaquine
Completed
- Malaria
- +4 more
- sulfadoxine-pyrimethamine (SP)
- dihydroartemisinin-piperaquine (DHA-PQP)
-
Handeni, Tanga Region, TanzaniaHandeni District Hospital
Feb 1, 2021
Artemether-Lumefantrine Effectiveness in Guinea-Bissau
Completed
- Malaria
-
Bissau, Bissau Codex, Guinea-BissauBandim Health Project
May 18, 2021
Malaria, Parasitic Diseases Trial in Anlong Veng (DHA-PIP, Primaquine, Artesunate + Mefloquine)
Active, not recruiting
- Malaria
- Parasitic Diseases
- DHA-PIP
- +3 more
-
Anlong Veng, Oddar Meancheay, CambodiaRCAF treatment facilities
Mar 1, 2021
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19
Unknown status
- COVID-19
- Severe Pneumonia
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
-
Zagreb, CroatiaUniversity Hospital for Infectious Diseases "Dr Fran Mihaljevic"
Nov 10, 2020
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Malaria Trial in Aweil (Sulfadoxine pyrimethamine, Amodiaquine)
Not yet recruiting
- Malaria
- Sulfadoxine pyrimethamine
- Amodiaquine
-
Aweil, Northern Bahr El Gazal, South SudanAweil South
Jul 21, 2022
Child Health Trial in Mbeya, Morogoro (ePOCT+)
Recruiting
- Child Health
- ePOCT+
-
Mbeya, Mbeya CC, Tanzania
- +39 more
May 6, 2022
Coronavirus Infections Trial in Fortaleza (Hydroxychloroquine, Ivermectin)
Recruiting
- Coronavirus Infections
-
Fortaleza, Ceará, BrazilDrug Research and Development Center (NPDM), Federal University
Oct 5, 2020
Maculopathy Trial (spectral domain optical coherence tomography, multifocal electroretinogram)
Completed
- Maculopathy
- spectral domain optical coherence tomography
- multifocal electroretinogram
- (no location specified)
Jan 24, 2018
Malaria, Malaria, Falciparum Trial in Choma (MDA with DHAp (Eurartesim), Focal MDA with DHAp (Eurartesim))
Completed
- Malaria
- Malaria, Falciparum
- MDA with DHAp (Eurartesim)
- Focal MDA with DHAp (Eurartesim)
-
Choma, Southern, ZambiaSouthern province medical office
Sep 11, 2020
Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus Rash Trial in Changsha (nicotinamide)
Unknown status
- Cutaneous Lupus Erythematosus
- Systemic Lupus Erythematosus Rash
-
Changsha, Hunan, ChinaThe Second Xiangya Hospital of Central South University
Jan 31, 2021
Covid-19, Malaria Trial in Ouagadougou, Kisumu (Artemether-lumefantrine (AL), Pyronaridine-artesunate (PA))
Recruiting
- Covid-19
- Malaria
- Artemether-lumefantrine (AL)
- Pyronaridine-artesunate (PA)
-
Ouagadougou, Burkina Faso
- +1 more
Feb 23, 2021
Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth Trial in Kinshasa, Eldoret (Malaria High-Sensitivity Rapid
Not yet recruiting
- Malaria,Falciparum
- +8 more
- Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
-
Kinshasa, Congo, The Democratic Republic of the
- +1 more
Feb 24, 2023
Drugs That Could Prevent Risk of Serious COVID-19 Infections or
Unknown status
- AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
- - Synthetic anti-malarial drugs
-
Créteil, FranceAssistance Publique Hôpitaux de Paris - CHU Henri Mondor
Apr 17, 2020
Vivax Malaria Trial in Jalalabad (Chloroquine, Primaquine 0.25 mg/kg/day, Primaquine 0.75 mg/kg weekly)
Completed
- Vivax Malaria
- Chloroquine
- +2 more
-
Jalalabad, Nangarha, AfghanistanDr. Ghulam Rahim Awab MD
Oct 9, 2020